TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Bioxyne Limited ( (AU:BXN) ) has provided an update.
Bioxyne Limited has updated its corporate governance statement, which is now available on its website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles, highlighting its commitment to transparency and accountability. This update reinforces Bioxyne’s dedication to maintaining high governance standards, potentially strengthening its position in the industry and reassuring stakeholders of its operational integrity.
More about Bioxyne Limited
Bioxyne Limited operates in the biotechnology industry, focusing on the development and commercialization of health and wellness products. The company is known for its probiotic and immune health products, targeting both domestic and international markets.
Average Trading Volume: 4,935,393
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$91.22M
See more data about BXN stock on TipRanks’ Stock Analysis page.